先进的混合闭环系统在囊性纤维化相关糖尿病中的有效性:试点研究
Marta Bassi1,2, Daniele Franzone2, Francesca Dufour2
1Pediatric Clinic, Endocrinology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Giannina Gaslini, Genoa, Italy.
Frontiers in endocrinology
|July 5, 2024
概括
先进的混合闭环 (AHCL) 系统显著改善了囊性纤维化相关糖尿病 (CFRD) 患者的血糖控制. 这项技术降低了HbA1c和胰岛素需求,为CFRD提供了一个有前途的新治疗途径.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 呼吸系统医学 呼吸系统医学
背景情况:
- 囊性纤维化相关糖尿病 (CFRD) 对营养状况和肺功能产生负面影响.
- 对于CFRD管理的新技术尚未得到充分探索.
- AHCL系统代表了糖尿病管理的新技术方法.
研究的目的:
- 评估先进混合闭环 (AHCL) 系统在改善CFRD患者的血糖控制方面的有效性.
- 评估AHCL对这一特定患者群体的关键血糖指标的影响.
主要方法:
- 在CFRD患者使用AHCL系统进行了一项回顾性单中心研究.
- 糖化血红素 (HbA1c) 和持续葡萄糖监测 (CGM) 数据在基线和1年的随访期内收集.
- 关键指标包括HbA1c,血糖变化,胰岛素需求,时间范围 (TIR) 和高血糖时间.
主要成果:
- 观察到HbA1c的统计显著降低 (p=0.03).
- 血糖变化和胰岛素需求也显著下降 (分别为p=0.05和p=0.03).
- 研究人口在一年内实现了美国糖尿病协会 (ADA) 的血糖目标,TIR趋势令人鼓舞,降低了高血糖.
结论:
- AHCL系统在改善CFRD患者的血糖控制方面表现出有效性,其证据是HbA1c和可变性降低.
- 虽然没有统计学意义,但观察到的TIR增加和高血糖减少在临床上是有希望的.
- 需要与更大的队列进行进一步的研究来证实这些发现,并探索AHCL在CFRD中的更广泛的益处,可能会影响营养和呼吸系统的结果.
相关概念视频
Cystic Fibrosis: Management
154
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
154
Cystic Fibrosis: Pathogenesis
205
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
205
Diabetes: Management and Pharmacotherapy
256
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
256
Carbohydrate Metabolism
11.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.0K
Chronic Pancreatitis II: Collaborative Care
84
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
84
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521


